SAN DIEGO — AI-based models are currently best utilized as a predictor of headache, but show promise for expansion into the health care continuum, according to a speaker at the American Headache Society Annual Scientific Meeting. “There’s a high demand among headache specialists or neurologists, so having such AI tools can really help get patients diagnosed earlier and get
AUSTIN, Texas — Treatment with 10 mg zavegepant nasal spray resulted in better quality of life as early as 12 weeks and through 1 year in adult patients with migraine, according to research presented here.“Migraine has been identified as one of the 10 most disabling medical disorders in the world,” Jelena M. Pavlovic, MD, PhD, assistant professor of neurology at Albert Einstein